Based on above features, up-regulated KIF23 has been considered as one of biomarkers in multiple tumors including lung cancer, malignant pleural mesothelioma, glioma and hepatocellular carcinoma [46, 47]. This evidence concerns the gene KIF23 and hepatocellular carcinoma.